$NRXP Surely they shouldn’t apply for full approval without the NIH data. NIH says it’s safe but the efficacy is blinded until trial is complete which I saw a recent post saying spring 2022. Is that correct? Realistically when would Zyesami be approved for anything by the FDA at this point?
3
3
3 Likes